320 related articles for article (PubMed ID: 29142505)
1. Targeting deubiquitinating enzymes in cancer stem cells.
Lei H; Shan H; Wu Y
Cancer Cell Int; 2017; 17():101. PubMed ID: 29142505
[TBL] [Abstract][Full Text] [Related]
2. Regulation of pluripotency and differentiation by deubiquitinating enzymes.
Suresh B; Lee J; Kim H; Ramakrishna S
Cell Death Differ; 2016 Aug; 23(8):1257-64. PubMed ID: 27285106
[TBL] [Abstract][Full Text] [Related]
3. The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance.
Qiu GZ; Sun W; Jin MZ; Lin J; Lu PG; Jin WL
Pharmacol Ther; 2017 Apr; 172():127-138. PubMed ID: 27919796
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinating Enzyme-Mediated Signaling Networks in Cancer Stem Cells.
Kaushal K; Ramakrishna S
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158118
[TBL] [Abstract][Full Text] [Related]
5. Concise Review: Fate Determination of Stem Cells by Deubiquitinating Enzymes.
Chandrasekaran AP; Suresh B; Kim HH; Kim KS; Ramakrishna S
Stem Cells; 2017 Jan; 35(1):9-16. PubMed ID: 27341175
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential.
Guo JN; Xia BR; Deng SH; Yang C; Pi YN; Cui BB; Jin WL
Front Cell Dev Biol; 2021; 9():680100. PubMed ID: 34179009
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating enzymes in cancer stem cells: functions and targeted inhibition for cancer therapy.
Kaushal K; Antao AM; Kim KS; Ramakrishna S
Drug Discov Today; 2018 Dec; 23(12):1974-1982. PubMed ID: 29864528
[TBL] [Abstract][Full Text] [Related]
8. The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming.
Suresh B; Lee J; Kim KS; Ramakrishna S
Stem Cells Int; 2016; 2016():6705927. PubMed ID: 26880980
[TBL] [Abstract][Full Text] [Related]
9. Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges.
Jin WL; Mao XY; Qiu GZ
Med Res Rev; 2017 May; 37(3):627-661. PubMed ID: 27775833
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion.
Hsu SK; Chou CK; Lin IL; Chang WT; Kuo IY; Chiu CC
Cell Commun Signal; 2024 May; 22(1):259. PubMed ID: 38715050
[TBL] [Abstract][Full Text] [Related]
11. Advances in deubiquitinating enzymes in lung adenocarcinoma.
Zhou XJ; Li R; Liu X; Qu YQ
J Cancer; 2021; 12(18):5573-5582. PubMed ID: 34405018
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitylating enzymes as cancer stem cell therapeutics.
Haq S; Suresh B; Ramakrishna S
Biochim Biophys Acta Rev Cancer; 2018 Jan; 1869(1):1-10. PubMed ID: 29054474
[TBL] [Abstract][Full Text] [Related]
13. p53 stability is regulated by diverse deubiquitinating enzymes.
Kwon SK; Saindane M; Baek KH
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):404-411. PubMed ID: 28801249
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitination and deubiquitination in the regulation of N
Zhao Y; Huang J; Zhao K; Li M; Wang S
J Mol Med (Berl); 2024 Mar; 102(3):337-351. PubMed ID: 38289385
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?
Poondla N; Chandrasekaran AP; Kim KS; Ramakrishna S
BMB Rep; 2019 Mar; 52(3):181-189. PubMed ID: 30760385
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinating enzymes in cellular signaling and disease regulation.
Hanpude P; Bhattacharya S; Dey AK; Maiti TK
IUBMB Life; 2015 Jul; 67(7):544-55. PubMed ID: 26178252
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes.
Cruz L; Soares P; Correia M
Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577547
[TBL] [Abstract][Full Text] [Related]
18. The role of deubiquitinases in breast cancer.
Xiao Z; Zhang P; Ma L
Cancer Metastasis Rev; 2016 Dec; 35(4):589-600. PubMed ID: 27844253
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication.
He M; Zhou Z; Wu G; Chen Q; Wan Y
Pharmacol Ther; 2017 Sep; 177():96-107. PubMed ID: 28279784
[TBL] [Abstract][Full Text] [Related]
20. Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code.
Wang Y; Wang F
Front Pharmacol; 2021; 12():685011. PubMed ID: 34177595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
